COHANCEstockCohance Lifesciences Ltd
₹424.05
▼-1.91%
Open
₹434.45
High
₹442
Low
₹423.75
Volume
768.6K
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹475.42026-06-18 · ₹415.55
Instrument details
- MB Code
- MBEQU5396
- Type
- stock
- ISIN
- INE03QK01018
- BSE
- 543064
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 619.12 Cr
- Net profit
- 8.31 Cr
- EPS
- 0.5
- YoY revenue
- +54.00%
Price returns
Historical performance
- 1 day
- -2.42%
- 1 month
- -3.24%
- 3 months
- +38.86%
- 1 year
- -58.72%
- 3 years
- -14.57%
- 5 years
- -13.33%
Technicals
Indicator consensus
Bullish
13
Neutral
5
Bearish
28
RSI 34.24(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
56Investor presentations
62Corporate announcements
330Corporate timeline
Price chart events · 1 year
Earnings
2025-08-13
{"actualRevenue":5493100000,"estimateRevenue":5618000000,"revenueSurprise":-124900000,"revenueSurprisePercent":-2.223211107155572,"actualEPS":1.48,"estimateEPS":1.6218,"surprise":-0.1418000000000001,"surprisePercent":-8.743371562461471}
Earnings
2026-05-12
{"actualRevenue":6191200000,"estimateRevenue":5865000000,"revenueSurprise":326200000,"revenueSurprisePercent":5.561807331628303,"actualEPS":0.92,"estimateEPS":1.4892,"surprise":-0.5692,"surprisePercent":-38.22186408810099}
Earnings
2026-02-12
{"actualRevenue":5445500000,"estimateRevenue":6167000000,"revenueSurprise":-721500000,"revenueSurprisePercent":-11.69936760175126,"actualEPS":1.09,"estimateEPS":3.2436,"surprise":-2.1536,"surprisePercent":-66.39536317671723}
Earnings
2025-11-12
{"actualRevenue":5555700000,"estimateRevenue":6066000000,"revenueSurprise":-510300000,"revenueSurprisePercent":-8.41246290801187,"actualEPS":1.93,"estimateEPS":1.53,"surprise":0.3999999999999999,"surprisePercent":26.1437908496732}
News
2026-05-13
{"description":"Cohance Lifesciences said Q4 net profit fell 83.8% to ₹20 crore and revenue declined 26.3% to ₹619.1 crore; it expects recovery only from 2HFY27.","url":"https://www.cnbctv18.com/market/stocks/cohance-lifesciences-share-price-q4fy26-net-profit-revenue-ebitda-margin-pipeline-outlook-ws-l-19904114.htm","sentiment":"Negative","domain":"CNBCTV18"}
News
2026-04-27
{"description":"Cohance Lifesciences rose 20% after appointing former Cipla CEO Umang Vohra as Executive Chairman from May 1, 2026 and Group CEO from May 20, 2026; Vivek Sharma stays advisor for nine months.","url":"https://www.businesstoday.in/markets/stocks/story/cohance-lifesciences-share-price-soared-20-today-heres-why-527559-2026-04-27","sentiment":"Positive","domain":"Business Today"}